Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-02-02 Sale |
2024-02-05 5:15 pm |
EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer |
209 | $28.49 | $5,954 | 42,337 (Direct) |
View |
| 2024-01-26 Sale |
2024-01-30 4:53 pm |
EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer |
49,325 | $25.66 | $1,265,539 | 106,372 (Direct) |
View |
| 2024-01-26 Sale |
2024-01-29 5:54 pm |
EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer |
26,017 | $25.38 | $660,370 | 115,425 (Direct) |
View |
| 2024-01-25 Sale |
2024-01-29 5:51 pm |
EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer |
600 | $25 | $15,000 | 104,444 (Direct) |
View |
| 2024-01-24 Sale |
2024-01-26 5:03 pm |
EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer |
11,900 | $25.01 | $297,621 | 245,522 (Direct) |
View |
| 2024-01-23 Sale |
2024-01-25 6:26 pm |
EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer |
16,386 | $25.01 | $409,790 | 184,834 (Direct) |
View |
| 2024-01-23 Sale |
2024-01-25 6:24 pm |
EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Executive Vice Chair |
35,000 | $24.98 | $874,200 | 638,449 (Indirect Direct) |
View |
| 2024-01-22 Sale |
2024-01-24 4:50 pm |
EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer |
35,066 | $22.68 | $795,191 | 189,176 (Direct) |
View |
| 2024-01-11 Sale |
2024-01-16 6:55 pm |
EyePoint Pharmaceuticals Inc. | EYEP | Ocumension Therapeutics Director |
1,910,500 | $19.45 | $37,159,225 | 100,221 (Direct) |
View |
| 2024-01-11 Sale |
2024-01-16 6:01 pm |
EyePoint Pharmaceuticals Inc. | EYPT | Liu Ye Director |
1,910,500 | $19.45 | $37,159,225 | 100,221 (Indirect) |
View |
| 2024-01-09 Purchase |
2024-01-11 4:00 pm |
EyePoint Pharmaceuticals Inc. | EYPT | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP 10% Owner |
855,000 | $19.94 | $17,051,100 | 6,893,235 (Indirect) |
View |
| 2024-01-08 Sale |
2024-01-10 4:53 pm |
EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer |
22,913 | $21.13 | $484,124 | 105,247 (Direct) |
View |
| 2023-12-13 Sale |
2023-12-15 5:14 pm |
EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer |
1,458 | $20 | $29,160 | 63,624 (Direct) |
View |
| 2023-12-08 Purchase |
2023-12-12 4:52 pm |
EyePoint Pharmaceuticals Inc. | EYPT | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP 10% Owner |
588,235 | $17 | $9,999,995 | 6,038,235 (Indirect) |
View |
| 2023-12-04 Sale(A) |
2023-12-11 4:15 pm |
EyePoint Pharmaceuticals Inc. | EYPT | Pine Michael Craig Chief Corp Dev.&Strat. Officer |
46,000 | $21.97 | $1,010,790 | 59,343 (Direct) |
View |
| 2023-12-05 Sale |
2023-12-07 9:21 pm |
EyePoint Pharmaceuticals Inc. | EYEP | Ocumension Therapeutics Director |
1,000,000 | $19.51 | $19,510,637 | 2,010,721 (Direct) |
View |
| 2023-12-05 Sale |
2023-12-07 9:03 pm |
EyePoint Pharmaceuticals Inc. | EYPT | Liu Ye Director |
1,000,000 | $19.51 | $19,510,637 | 2,010,721 (Indirect) |
View |
| 2023-12-04 Sale |
2023-12-06 5:20 pm |
EyePoint Pharmaceuticals Inc. | EYPT | Pine Michael Craig Chief Corp Dev.&Strat. Officer |
45,000 | $22 | $990,000 | 60,343 (Direct) |
View |
| 2023-12-04 Sale |
2023-12-06 5:19 pm |
EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer |
30,625 | $22 | $673,750 | 65,082 (Direct) |
View |
| 2023-12-04 Sale |
2023-12-06 5:18 pm |
EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Executive Vice Chair |
20,000 | $20.76 | $415,200 | 170,559 (Direct) |
View |
| 2023-12-04 Purchase |
2023-12-06 4:39 pm |
EyePoint Pharmaceuticals Inc. | EYPT | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP 10% Owner |
1,919,057 | $21.82 | $41,874,151 | 5,450,000 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-09 Tax Withholding |
2024-02-13 5:39 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer |
5,083 | $28.8 | 48,056 (Direct) |
View |
| 2024-02-09 Exercise |
2024-02-13 5:39 pm |
N/A 2031-02-09 |
EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer |
10,800 | $0 | 48,056 (Direct) |
View |
| 2024-02-09 Tax Withholding |
2024-02-13 5:38 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer |
3,656 | $28.8 | 49,916 (Direct) |
View |
| 2024-02-09 Exercise |
2024-02-13 5:38 pm |
N/A 2031-02-09 |
EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer |
9,967 | $0 | 49,916 (Direct) |
View |
| 2024-02-09 Tax Withholding |
2024-02-13 5:38 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Elston George Chief Financial Officer |
3,192 | $28.8 | 49,441 (Direct) |
View |
| 2024-02-09 Exercise |
2024-02-13 5:38 pm |
N/A 2031-02-09 |
EyePoint Pharmaceuticals Inc. | EYPT | Elston George Chief Financial Officer |
10,800 | $0 | 49,441 (Direct) |
View |
| 2024-02-09 Tax Withholding |
2024-02-13 5:37 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO |
3,533 | $28.8 | 58,920 (Direct) |
View |
| 2024-02-09 Exercise |
2024-02-13 5:37 pm |
N/A 2031-02-09 |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO |
11,967 | $0 | 58,920 (Direct) |
View |
| 2024-02-02 Exercise |
2024-02-05 5:15 pm |
N/A 2031-11-01 |
EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer |
209 | $0 | 42,337 (Direct) |
View |
| 2024-02-02 Exercise |
2024-02-05 5:15 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer |
209 | $11.47 | 42,337 (Direct) |
View |
| 2024-01-26 Exercise |
2024-01-30 4:53 pm |
N/A 2031-02-09 |
EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer |
49,325 | $0 | 106,372 (Direct) |
View |
| 2024-01-26 Exercise |
2024-01-30 4:53 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer |
33,716 | $13.13 | 106,372 (Direct) |
View |
| 2024-01-26 Exercise |
2024-01-30 4:53 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer |
15,609 | $12.9 | 106,372 (Direct) |
View |
| 2024-01-26 Exercise |
2024-01-29 5:54 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer |
16,413 | $3.26 | 115,425 (Direct) |
View |
| 2024-01-26 Exercise |
2024-01-29 5:54 pm |
N/A 2030-02-28 |
EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer |
26,017 | $0 | 115,425 (Direct) |
View |
| 2024-01-26 Exercise |
2024-01-29 5:54 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer |
9,604 | $12.9 | 115,425 (Direct) |
View |
| 2024-01-25 Exercise |
2024-01-29 5:51 pm |
N/A 2031-02-09 |
EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer |
600 | $0 | 104,444 (Direct) |
View |
| 2024-01-25 Exercise |
2024-01-29 5:51 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer |
300 | $13.13 | 104,444 (Direct) |
View |
| 2024-01-25 Exercise |
2024-01-29 5:51 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer |
300 | $12.9 | 104,444 (Direct) |
View |
| 2024-01-24 Exercise |
2024-01-26 5:03 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer |
6,000 | $3.26 | 245,522 (Direct) |
View |
| 2024-01-24 Exercise |
2024-01-26 5:03 pm |
N/A 2030-02-28 |
EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer |
11,900 | $0 | 245,522 (Direct) |
View |
| 2024-01-24 Exercise |
2024-01-26 5:03 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer |
5,900 | $12.9 | 245,522 (Direct) |
View |
| 2024-01-23 Exercise |
2024-01-25 6:26 pm |
N/A 2031-02-09 |
EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer |
16,386 | $0 | 184,834 (Direct) |
View |
| 2024-01-23 Exercise |
2024-01-25 6:26 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer |
8,696 | $13.13 | 184,834 (Direct) |
View |
| 2024-01-23 Exercise |
2024-01-25 6:26 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer |
7,690 | $12.9 | 184,834 (Direct) |
View |
| 2024-01-24 Gift |
2024-01-25 6:24 pm |
N/A 2033-01-05 |
EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Executive Vice Chair |
225,400 | $0 | 638,449 (Direct) |
View |
| 2024-01-23 Exercise |
2024-01-24 4:50 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer |
500 | $3.26 | 189,176 (Direct) |
View |
| 2024-01-22 Exercise |
2024-01-24 4:50 pm |
N/A 2031-11-01 |
EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer |
35,066 | $0 | 189,176 (Direct) |
View |
| 2024-01-22 Exercise |
2024-01-24 4:50 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer |
5,416 | $11.47 | 189,176 (Direct) |
View |
| 2024-01-23 Exercise |
2024-01-24 4:50 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer |
400 | $12.9 | 189,176 (Direct) |
View |
| 2024-01-22 Exercise |
2024-01-24 4:50 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer |
28,750 | $10.13 | 189,176 (Direct) |
View |
| 2024-01-08 Exercise |
2024-01-10 4:53 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer |
22,913 | $3.26 | 105,247 (Direct) |
View |
| 2024-01-08 Exercise |
2024-01-10 4:53 pm |
N/A 2033-01-05 |
EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer |
22,913 | $0 | 105,247 (Direct) |
View |
| 2024-01-06 Exercise |
2024-01-09 9:28 pm |
N/A 2033-06-19 |
EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer |
15,285 | $0 | 130,075 (Direct) |
View |
| 2024-01-06 Tax Withholding |
2024-01-09 9:28 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer |
4,487 | $20.4 | 130,075 (Direct) |
View |
| 2024-01-05 Option Award |
2024-01-09 9:28 pm |
N/A 2034-01-05 |
EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer |
63,000 | $0 | 130,075 (Direct) |
View |
| 2024-01-06 Exercise |
2024-01-09 9:17 pm |
N/A 2033-06-19 |
EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Executive Vice Chair |
75,133 | $0 | 435,708 (Direct) |
View |
| 2024-01-06 Tax Withholding |
2024-01-09 9:17 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Executive Vice Chair |
23,043 | $20.4 | 435,708 (Direct) |
View |
| 2024-01-05 Option Award |
2024-01-09 9:17 pm |
N/A 2034-01-05 |
EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Executive Vice Chair |
115,000 | $0 | 435,708 (Direct) |
View |
| 2024-01-05 Option Award |
2024-01-09 9:12 pm |
2025-01-05 2034-01-04 |
EyePoint Pharmaceuticals Inc. | EYPT | Zaderej Karen L. Director |
25,014 | $0 | 25,014 (Direct) |
View |
| 2024-01-06 Exercise |
2024-01-09 9:11 pm |
N/A 2033-06-19 |
EyePoint Pharmaceuticals Inc. | EYPT | Pine Michael Craig Chief Corp Dev.&Strat. Officer |
15,285 | $0 | 107,232 (Direct) |
View |
| 2024-01-06 Tax Withholding |
2024-01-09 9:11 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Pine Michael Craig Chief Corp Dev.&Strat. Officer |
5,966 | $20.4 | 107,232 (Direct) |
View |
| 2024-01-05 Option Award |
2024-01-09 9:11 pm |
N/A 2034-01-05 |
EyePoint Pharmaceuticals Inc. | EYPT | Pine Michael Craig Chief Corp Dev.&Strat. Officer |
63,000 | $0 | 107,232 (Direct) |
View |
| 2024-01-06 Exercise |
2024-01-09 9:09 pm |
N/A 2033-06-19 |
EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer |
15,285 | $0 | 131,532 (Direct) |
View |
| 2024-01-06 Tax Withholding |
2024-01-09 9:09 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer |
4,147 | $20.4 | 131,532 (Direct) |
View |
| 2024-01-05 Option Award |
2024-01-09 9:09 pm |
N/A 2034-01-05 |
EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer |
63,000 | $0 | 131,532 (Direct) |
View |
| 2024-01-06 Exercise |
2024-01-09 9:07 pm |
N/A 2033-06-19 |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO |
20,793 | $0 | 355,073 (Direct) |
View |
| 2024-01-06 Tax Withholding |
2024-01-09 9:07 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO |
6,528 | $20.4 | 355,073 (Direct) |
View |
| 2024-01-05 Option Award |
2024-01-09 9:07 pm |
N/A 2034-01-05 |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO |
270,000 | $0 | 355,073 (Direct) |
View |
| 2024-01-06 Exercise |
2024-01-09 9:04 pm |
N/A 2033-06-19 |
EyePoint Pharmaceuticals Inc. | EYPT | Elston George Chief Financial Officer |
15,285 | $0 | 200,878 (Direct) |
View |
| 2024-01-06 Tax Withholding |
2024-01-09 9:04 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Elston George Chief Financial Officer |
4,911 | $20.4 | 200,878 (Direct) |
View |
| 2024-01-05 Option Award |
2024-01-09 9:04 pm |
N/A 2034-01-05 |
EyePoint Pharmaceuticals Inc. | EYPT | Elston George Chief Financial Officer |
135,000 | $0 | 200,878 (Direct) |
View |
| 2024-01-05 Option Award |
2024-01-09 8:56 pm |
2025-01-05 2034-01-04 |
EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director |
25,014 | $0 | 25,014 (Direct) |
View |
| 2024-01-05 Option Award |
2024-01-09 8:55 pm |
2025-01-05 2034-01-04 |
EyePoint Pharmaceuticals Inc. | EYPT | Landis John B. Director |
55,014 | $0 | 55,014 (Direct) |
View |
| 2024-01-05 Option Award |
2024-01-09 8:54 pm |
2025-01-05 2034-01-04 |
EyePoint Pharmaceuticals Inc. | EYPT | Duty Stuart Director |
25,014 | $0 | 25,014 (Direct) |
View |
| 2024-01-05 Option Award |
2024-01-09 8:54 pm |
2025-01-05 2034-01-04 |
EyePoint Pharmaceuticals Inc. | EYPT | DICICCO WENDY F Director |
25,014 | $0 | 25,014 (Direct) |
View |
| 2024-01-05 Option Award |
2024-01-09 8:53 pm |
2025-01-05 2034-01-04 |
EyePoint Pharmaceuticals Inc. | EYPT | ANDO GORAN Director |
23,598 | $0 | 23,598 (Direct) |
View |
| 2024-01-05 Option Award |
2024-01-09 8:53 pm |
2025-01-05 2034-01-04 |
EyePoint Pharmaceuticals Inc. | EYPT | ADAMIS ANTHONY P Director |
25,014 | $0 | 25,014 (Direct) |
View |
| 2023-12-28 Gift(A) |
2024-01-03 6:37 pm |
N/A 2031-02-09 |
EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Executive Vice Chair |
206,348 | $0 | 699,059 (Direct) |
View |
| 2023-12-28 Gift |
2024-01-02 5:41 pm |
N/A 2031-02-09 |
EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Executive Vice Chair |
154,140 | $0 | 528,500 (Direct) |
View |
| 2023-12-13 Exercise |
2023-12-15 5:14 pm |
N/A 2032-02-09 |
EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer |
1,458 | $0 | 63,624 (Direct) |
View |
| 2023-12-13 Exercise |
2023-12-15 5:14 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer |
1,458 | $10.13 | 63,624 (Direct) |
View |
| 2023-12-04 Exercise(A) |
2023-12-11 4:15 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Pine Michael Craig Chief Corp Dev.&Strat. Officer |
45,000 | $12.62 | 59,343 (Direct) |
View |
| 2023-12-04 Exercise(A) |
2023-12-11 4:15 pm |
N/A 2032-01-10 |
EyePoint Pharmaceuticals Inc. | EYPT | Pine Michael Craig Chief Corp Dev.&Strat. Officer |
45,000 | $0 | 59,343 (Direct) |
View |
| 2023-12-04 Exercise |
2023-12-06 5:20 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Pine Michael Craig Chief Corp Dev.&Strat. Officer |
45,000 | $12.62 | 60,343 (Direct) |
View |
| 2023-12-04 Exercise |
2023-12-06 5:20 pm |
N/A 2032-01-10 |
EyePoint Pharmaceuticals Inc. | EYPT | Pine Michael Craig Chief Corp Dev.&Strat. Officer |
45,000 | $0 | 60,343 (Direct) |
View |
| 2023-12-04 Exercise |
2023-12-06 5:19 pm |
N/A 2032-02-09 |
EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer |
30,625 | $0 | 65,082 (Direct) |
View |
| 2023-12-04 Exercise |
2023-12-06 5:19 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer |
30,625 | $10.13 | 65,082 (Direct) |
View |